Sapient Capital LLC Liquidia Corp Transaction History
Sapient Capital LLC
- $4.93 Billion
- Q3 2024
A detailed history of Sapient Capital LLC transactions in Liquidia Corp stock. As of the latest transaction made, Sapient Capital LLC holds 133,600 shares of LQDA stock, worth $1.43 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
133,600Holding current value
$1.43 Million% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding LQDA
# of Institutions
171Shares Held
44.3MCall Options Held
1.55MPut Options Held
1.52M-
Patient Square Capital LP Menlo Park, CA7.18MShares$76.8 Million26.66% of portfolio
-
Black Rock Inc. New York, NY4.24MShares$45.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$36.8 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.29MShares$35.2 Million0.17% of portfolio
-
Findell Capital Management LLC New York, NY3.19MShares$34.1 Million16.08% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $688M
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...